Covered recipient · General Payments record
DIANA NA COBOS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$425.84
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.84 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $280.35 | 10 |
| Exact Sciences Corporation | $75.52 | 3 |
| Ardelyx, Inc. | $52.93 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.04 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $425.84 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | $30.67 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146722300 | CMS |
| Ardelyx, Inc. | $22.26 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146722302 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.04 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118133457 | CMS |
| Exact Sciences Corporation | $26.75 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114536922 | CMS |
| Exact Sciences Corporation | $23.63 | 08/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114536913 | CMS |
| Exact Sciences Corporation | $25.14 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114536918 | CMS |
| Novo Nordisk Inc | $24.98 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100586502 | CMS |
| Novo Nordisk Inc | $15.19 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100337751 | CMS |
| Novo Nordisk Inc | $7.01 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226086 | CMS |
| Novo Nordisk Inc | $22.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100503223 | CMS |
| Novo Nordisk Inc | $22.98 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100561743 | CMS |
| Novo Nordisk Inc | $122.26 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653931 | CMS |
| Novo Nordisk Inc | $21.52 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100642694 | CMS |
| Novo Nordisk Inc | $9.56 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100395554 | CMS |
| Novo Nordisk Inc | $23.77 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100372798 | CMS |
| Novo Nordisk Inc | $10.53 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100621276 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.